SOLV
Solventum Corp.
NYSE: SOLV · HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES
$66.49
-1.51% today
Updated 2026-04-29
Market cap
$11.54B
P/E ratio
7.49
P/S ratio
1.39x
EPS (TTM)
$8.88
Dividend yield
—
52W range
$62 – $88
Volume
1.3M
Solventum Corp. (SOLV) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | — | $14.07B | $13.59B | $13.94B | $14.46B |
| Cash & equivalents | — | $91.00M | $61.00M | $194.00M | $762.00M |
| Current assets | — | $2.19B | $2.23B | $2.52B | $3.25B |
| Total liabilities | — | $2.02B | $1.85B | $2.28B | $11.50B |
| Current liabilities | — | $1.41B | $1.31B | $1.73B | $2.70B |
| Long-term debt | — | — | — | $8.30B | $7.81B |
| Shareholder equity | — | $12.06B | $11.74B | $11.67B | $2.96B |
| Retained earnings | — | — | — | $0.00 | $242.00M |
| Accounts receivable | — | $1.18B | $1.17B | $1.31B | $1.23B |
| Inventory | — | $813.00M | $873.00M | $857.00M | $965.00M |
| Goodwill | — | $6.67B | $6.43B | $6.54B | $6.38B |